Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.

A randomised, double blind, placebo controlled, crossover study of digoxin withdrawal and reintroduction was carried out over two periods of eight weeks each after long term treatment. Forty four patients with stable heart failure in sinus rhythm and plasma digoxin concentrations over 0.8 ng/ml were...

Full description

Bibliographic Details
Main Authors: Pugh, SE, White, N, Aronson, J, Grahame-Smith, D, Bloomfield, J
Format: Journal article
Language:English
Published: BMJ Publishing Group 1989
_version_ 1826260309454618624
author Pugh, SE
White, N
Aronson, J
Grahame-Smith, D
Bloomfield, J
author_facet Pugh, SE
White, N
Aronson, J
Grahame-Smith, D
Bloomfield, J
author_sort Pugh, SE
collection OXFORD
description A randomised, double blind, placebo controlled, crossover study of digoxin withdrawal and reintroduction was carried out over two periods of eight weeks each after long term treatment. Forty four patients with stable heart failure in sinus rhythm and plasma digoxin concentrations over 0.8 ng/ml were studied. Their progress was assessed by clinical criteria, by haemodynamic measurements (systolic time intervals and echocardiography), and by pharmacological measurements of erythrocytic sodium pump numbers and activity. After withdrawal of digoxin clinical deterioration occurred in only 25% of the patients. Furthermore, in only 9% of cases was digoxin reintroduction thought to be necessary. There was deterioration in only 11% of the patients during digoxin treatment. Deterioration during digoxin withdrawal was accompanied by changes in systolic time intervals, but similar, albeit smaller changes in systolic time intervals also occurred in patients with no deterioration. Deterioration was accompanied by changes in the pharmacological effects of digoxin on the erythrocytes, consistent with a loss of effect, and these changes did not occur in those who did not deteriorate. The occurrence of deterioration could not be predicted by any clinical, haemodynamic, or pharmacological measurements made before withdrawal.
first_indexed 2024-03-06T19:03:35Z
format Journal article
id oxford-uuid:145ed52a-6fc1-45fe-bb5c-d67a8a8c309a
institution University of Oxford
language English
last_indexed 2024-03-06T19:03:35Z
publishDate 1989
publisher BMJ Publishing Group
record_format dspace
spelling oxford-uuid:145ed52a-6fc1-45fe-bb5c-d67a8a8c309a2022-03-26T10:19:24ZClinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:145ed52a-6fc1-45fe-bb5c-d67a8a8c309aEnglishSymplectic Elements at OxfordBMJ Publishing Group1989Pugh, SEWhite, NAronson, JGrahame-Smith, DBloomfield, JA randomised, double blind, placebo controlled, crossover study of digoxin withdrawal and reintroduction was carried out over two periods of eight weeks each after long term treatment. Forty four patients with stable heart failure in sinus rhythm and plasma digoxin concentrations over 0.8 ng/ml were studied. Their progress was assessed by clinical criteria, by haemodynamic measurements (systolic time intervals and echocardiography), and by pharmacological measurements of erythrocytic sodium pump numbers and activity. After withdrawal of digoxin clinical deterioration occurred in only 25% of the patients. Furthermore, in only 9% of cases was digoxin reintroduction thought to be necessary. There was deterioration in only 11% of the patients during digoxin treatment. Deterioration during digoxin withdrawal was accompanied by changes in systolic time intervals, but similar, albeit smaller changes in systolic time intervals also occurred in patients with no deterioration. Deterioration was accompanied by changes in the pharmacological effects of digoxin on the erythrocytes, consistent with a loss of effect, and these changes did not occur in those who did not deteriorate. The occurrence of deterioration could not be predicted by any clinical, haemodynamic, or pharmacological measurements made before withdrawal.
spellingShingle Pugh, SE
White, N
Aronson, J
Grahame-Smith, D
Bloomfield, J
Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
title Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
title_full Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
title_fullStr Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
title_full_unstemmed Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
title_short Clinical, haemodynamic, and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment.
title_sort clinical haemodynamic and pharmacological effects of withdrawal and reintroduction of digoxin in patients with heart failure in sinus rhythm after long term treatment
work_keys_str_mv AT pughse clinicalhaemodynamicandpharmacologicaleffectsofwithdrawalandreintroductionofdigoxininpatientswithheartfailureinsinusrhythmafterlongtermtreatment
AT whiten clinicalhaemodynamicandpharmacologicaleffectsofwithdrawalandreintroductionofdigoxininpatientswithheartfailureinsinusrhythmafterlongtermtreatment
AT aronsonj clinicalhaemodynamicandpharmacologicaleffectsofwithdrawalandreintroductionofdigoxininpatientswithheartfailureinsinusrhythmafterlongtermtreatment
AT grahamesmithd clinicalhaemodynamicandpharmacologicaleffectsofwithdrawalandreintroductionofdigoxininpatientswithheartfailureinsinusrhythmafterlongtermtreatment
AT bloomfieldj clinicalhaemodynamicandpharmacologicaleffectsofwithdrawalandreintroductionofdigoxininpatientswithheartfailureinsinusrhythmafterlongtermtreatment